we evaluated the type specificity of complement-fixing ( cf ) antibody against the ag-4 early antigen of herpes simplex virus ( hsv ) type 2 ( hsv-2 ) by comparing a commercial ag-4 cf kit ( simplex-2 ; gene link australia , inc. , princeton , n.j. ) with quantal microneutralization ( mn ) and absorption-western blotting in testing sera from patients with and without a history of genital herpes .
C0009498
cf
C0229671
sera